Toxicity of extended adjuvant therapy with aromatase inhibitors in early breast cancer: a systematic review and meta-analysis
H Goldvaser, TA Barnes, B Šeruga… - JNCI: Journal of the …, 2018 - academic.oup.com
Background A number of randomized controlled trials (RCTs) have reported improvement in
breast cancer outcomes from extending treatment with aromatase inhibitors (AIs) beyond the …
breast cancer outcomes from extending treatment with aromatase inhibitors (AIs) beyond the …
Extended adjuvant endocrine therapy for postmenopausal women: Treating many to benefit a few
PR Pohlmann, C Isaacs - JNCI: Journal of the National Cancer …, 2018 - academic.oup.com
Over the last decade, a number of phase III multinational randomized clinical trials (RCTs)
have evaluated the benefit of extending adjuvant endocrine therapy with an aromatase …
have evaluated the benefit of extending adjuvant endocrine therapy with an aromatase …